Barclays Maintains Equal-Weight on Lennox Intl, Raises Price Target to $517
Barclays analyst Julian Mitchell maintains Lennox Intl (NYSE:LII) with a Equal-Weight and raises the price target from $500 to $517.
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $6,200 Today
Lennox Intl (NYSE:LII) has outperformed the market over the past 10 years by 9.05% on an annualized basis producing an average annual return of 20.08%. Currently, Lennox Intl has a market
Citi Upgrades Illumina, Quest, Agilent to Buy, Downgrades Avantor
What's Going On With 10x Genomics Stock On Wednesday?
Wednesday, Illumina Inc (NASDAQ:ILMN) acquired Fluent BioSciences to expand its reach in single-cell analysis and multiomics research for an undisclosed consideration.Amid this M&A deal, 10x Genomics,
Illumina Buys Fluent BioSciences To Gain Stronger Foothold In Single-Cell Analysis
Last month, Illumina Inc (NASDAQ:ILMN) had to let go of Grail Inc. Still, the DNA sequencing company has acquired Fluent BioSciences to expand its reach in single-cell analysis and multiomics
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,800 Today
Reliance (NYSE:RS) has outperformed the market over the past 10 years by 3.43% on an annualized basis producing an average annual return of 14.4%. Currently, Reliance has a market capitalization of $1
The Analyst Verdict: Lennox Intl In The Eyes Of 9 Experts
Across the recent three months, 9 analysts have shared their insights on Lennox Intl (NYSE:LII), expressing a variety of opinions spanning from bullish to bearish.The following table encapsulates
10x Genomics Stock Slides 14% Amid Illumina Deal, Deutsche Downgrade
Goldman Sachs Maintains Buy on Lennox Intl, Raises Price Target to $575
Goldman Sachs analyst Joe Ritchie maintains Lennox Intl (NYSE:LII) with a Buy and raises the price target from $507 to $575.
Insights Into Pure Storage's Performance Versus Peers In Technology Hardware, Storage & Peripherals Sector
In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article, we will perform a
SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 0.4% on Wednesday.Shares of SMART Global Holdings, Inc. (NASDAQ:SGH) rose sharply during Wednesday's session after the
Earlier, Relmada Therapeutics Announced Publication Of Results From The Phase 3 Reliance I Study of REL-1017 In The Journal Of Clinical Psychiatry
Relmada Therapeutics, Inc. (NASDAQ:RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced the publication of REL-1017 clinical data from
Lennox Intl Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/10/2024 7.23% Wells Fargo $550 → $570 Downgrades Overweight → Equal-Weight 06/21/2024 12.88% TD Cowen $
Lennox International Downgraded at Wells Fargo After Recent Outperformance
Stephens & Co. Reiterates Overweight on Illumina, Maintains $170 Price Target
Stephens & Co. analyst Mason Carrico reiterates Illumina (NASDAQ:ILMN) with a Overweight and maintains $170 price target.
Illumina Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/10/2024 26.7% Citigroup → $140 Upgrades Neutral → Buy 07/01/2024 119% RBC Capital $249 → $242
Illumina Acquires Fluent BioSciences, Enhancing Single-Cell Technology Capabilities; Advances Multiomics Growth Strategy
Illumina Acquires Fluent BioSciences, Enhancing Single-Cell Technology Capabilities; Advances Multiomics Growth
BMO Sees BMRN, LEGN, SLN as Attractive M&A Targets
BMO Says S&P 500 Bull Case of 6,000 Appears Feasible With Backdrop Supportive for Stocks
BMO Capital Markets said its 5,600 year-end call for the S&P 500 (SP500)(SPY)(IVV) may end up being conservative as momentum continues to run strongly in the market.
Only Mega-cap Outperforms More Than 15% YTD